Crizotinib (Xalkori▼): risk of cardiac failure

Source:
GOV UK
Publisher:
Medicines and Healthcare products Regulatory Agency
Publication date:
12 November 2015

Abstract

There have been reports of severe, sometimes fatal, cases of cardiac failure in patients treated with crizotinib.